Caris Life Sciences, Inc. is 1.1x more valuable than RadNet, Inc. by market capitalization ($5.08 B vs $4.46 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAI | RDNT |
|---|---|---|
| Market cap | $5.08 B | $4.46 B |
| US-listed rank | #1396 | #1506 |
| Revenue (latest FY) | $812.03M | $2.04B |
| Net income (latest FY) | -$68.09M | -$18.65M |
| Net margin | -8.4% | -0.9% |
| SEC filings | 102 | 1,345 |
Caris Life Sciences, Inc. is 1.1x more valuable than RadNet, Inc. by market capitalization ($5.08 B vs $4.46 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while RadNet, Inc. reported $2.04B.
Full pages: Caris Life Sciences, Inc. and RadNet, Inc., or browse the full rankings.